Last reviewed · How we verify
NCT05348603
Electronic Health Record Strategies to Promote Diverse Participation in Research
NA trial testing Traditional Letter in Patient Participation in 726,199 participants. Completed in 14 November 2023.
15 May 2023
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | other |
| Enrollment | 726,199 |
| Start date | 13 September 2022 |
| Primary completion | 15 May 2023 |
| Estimated completion | 14 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Traditional Letter
- Direct to Patient Message
- Chatbot
- Banner
Conditions studied
- Patient Participation — all drugs for Patient Participation →
Sponsor
Yale University
Who can join
18 and older, any sex, with Patient Participation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine the effectiveness of enhanced features in an online patient portal including banners, a chatbot, and direct to patient message and traditional mailed letters on increasing interest in research among online patient portal users.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05348603
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Traditional Letter
Trials testing the same drug.
- NCT06467487 — Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2 · NA · completed
Other recruiting trials for Patient Participation
Currently open trials in the same condition.
- NCT06722352 — Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) · NA · recruiting
- NCT06322264 — Promoting Children's Participation in Conventional X-ray Examinations · recruiting
- NCT06337214 — TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy · NA · recruiting
- NCT05866393 — Clean Hands Accessible and Manageable for Patients (CHAMPs) · NA · recruiting
- NCT05779449 — Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS · NA · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05348603 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 11 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05348603.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing